Ellington Management Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-26,000
Closed -$403K 618
2019
Q3
$403K Buy
+26,000
New +$428K 0.07% 276
2018
Q2
Sell
-15,500
Closed -$304K 632
2018
Q1
$304K Buy
+15,500
New +$300K 0.02% 590
2017
Q2
Sell
-68,400
Closed -$886K 746
2017
Q1
$886K Buy
+68,400
New +$865K 0.03% 121
2016
Q4
Sell
-64,300
Closed -$777K 643
2016
Q3
$777K Buy
+64,300
New +$657K 0.21% 126
2016
Q2
Sell
-15,000
Closed -$142K 346
2016
Q1
$142K Buy
+15,000
New +$141K 0.06% 451
2015
Q4
Sell
-16,472
Closed -$221K 676
2015
Q3
$221K Buy
+16,472
New +$331K 0.06% 542
2015
Q1
Sell
-12,200
Closed -$118K 736
2014
Q4
$118K Buy
+12,200
New +$108K 0.04% 517
2014
Q3
Sell
-13,900
Closed -$137K 358
2014
Q2
$137K Buy
+13,900
New +$118K 0.06% 393
2013
Q4
Sell
-33,500
Closed -$370K 647
2013
Q3
$370K Buy
+33,500
New +$279K 0.07% 436

Other funds holding HALO

Ellington Management Group's HALO Position: Q4 2019 in Review

Ellington Management Group sold out of Halozyme (HALO) in Q4 2019, closing a stake of 26,000 shares — an estimated $403K sold.

Ellington Management Group first reported a position in HALO in Q3 2013 and held it in 9 quarters. The position peaked at $886K in Q1 2017. 224 funds tracked by Wall St. Rank hold HALO as of Q4 2019.

  • Ellington Management Group reported no remaining Halozyme position as of Q4 2019 after selling out during the quarter.
  • Ellington Management Group sold 26,000 Halozyme shares in Q4 2019, an estimated $403K.
  • Ellington Management Group first reported a position in Halozyme in Q3 2013 and held it in 9 quarters.
  • Ellington Management Group's Halozyme position peaked at $886K in Q1 2017.
  • 224 funds tracked by Wall St. Rank held Halozyme as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.